News Archives - EsoCap Biotech

Professor Werner Weitschies Receives the 2026 Pearls of Bioequivalence and Biopharmaceutics Award for Groundbreaking Esophageal Drug Delivery Innovation

Post author:esocap
Post published:June 5, 2026
Post category:News

EsoCap is proud to congratulate Professor Werner Weitschies of the Institute of Pharmacy, Center of Drug Absorption and Transport – Biopharmaceutics and Pharmaceutical Technology at the University of Greifswald, on…

University of Greifswald Pioneers 3D-Printed Mucoadhesive Films for Individualized Esophageal Drug Delivery

Post author:esocap
Post published:October 1, 2025
Post category:News

A research team at the University of Greifswald has published groundbreaking findings in the European Journal of Pharmaceutical Sciences, presenting a novel approach to individualized drug delivery using 3D printed…

Most cited – Greifswald scientist & EsoCap co-founder tops the list of ‘Highly Cited Researchers’

Post author:esocap
Post published:November 29, 2023
Post category:News

For the second time in succession, pharmacist Prof. Werner Weitschies from the University of Greifswald‘s Institute for Pharmacy is one of the most frequently cited researchers in the world in…

EsoCap completes patient recruitment in ACESO phase II trial in eosinophilic esophagitis

Post author:esocap
Post published:September 5, 2023
Post category:News

EsoCap's novel targeted delivery platform is designed to increase mucosal contact time and drug deposition in the esophagus ESO-101, EsoCap's lead product candidate, consists of a capsule with a rolled-up,…

EsoCap was featured in GoingPublic Magazine

Post author:esocap
Post published:April 12, 2023
Post category:News

EsoCap AG has been selected to be featured in GoingPublic Magazine, a major German magazine for corporate finance and investment topics. "We are very pleased to be featured in GoingPublic…

EsoCap announces data presentation at the European Conference on Pharmaceutics.

Post author:esocap
Post published:March 21, 2023
Post category:News

EsoCap AG announced the presentation of data showing that for the first time, long-lasting topical drug therapy in the esophagus is possible with the EsoCap smart delivery technology in the…

EsoCap CEO interviewed by CCFA

Post author:esocap
Post published:February 24, 2023
Post category:Featured News

EsoCap CEO interviewed by CCFA as part of International Women's Day. "I am very pleased to have been selected to give an interview in Caléidoscope, the journal of the CCFA…

EsoCap Announces Publication “Development of a Hot- Melt Extrusion-Based Spinning Process to Produce Pharmaceutical Fibers and Yarns”

Post author:esocap
Post published:June 23, 2022
Post category:News

EsoCap has announced that scientists from the University of Greifswald have published important data regarding a hot-melt extrusion-based spinning process to produce pharmaceutical fibers and yarns. This spinning process is…

EsoCap holds a multidisciplinary advisory board meeting on Barrett’s esophagus

Post author:esocap
Post published:June 14, 2022
Post category:News

EsoCap AG organized a multidisciplinary scientific advisory board meeting with eight international experts in Barrett’s esophagus (BE) in Zurich EsoCap’s technology for the topical treatment of Barrett’s esophagus was recognized…

EsoCap supports first European EoE Day of the European Society of Eosinophilic Oesophagitis on May 22, 2022

Post author:esocap
Post published:May 20, 2022
Post category:News

Patients with eosinophilic esophagitis (EoE) suffer from severe symptoms including swallowing disorders, food impaction, vomiting, and heartburn EsoCap is currently conducting a randomized, placebo-controlled, double-blind Phase II trial to treat…

Professor Werner Weitschies Receives the 2026 Pearls of Bioequivalence and Biopharmaceutics Award for Groundbreaking Esophageal Drug Delivery Innovation

University of Greifswald Pioneers 3D-Printed Mucoadhesive Films for Individualized Esophageal Drug Delivery

Most cited – Greifswald scientist & EsoCap co-founder tops the list of ‘Highly Cited Researchers’

EsoCap completes patient recruitment in ACESO phase II trial in eosinophilic esophagitis

EsoCap was featured in GoingPublic Magazine

EsoCap announces data presentation at the European Conference on Pharmaceutics.

EsoCap CEO interviewed by CCFA

EsoCap Announces Publication “Development of a Hot- Melt Extrusion-Based Spinning Process to Produce Pharmaceutical Fibers and Yarns”

EsoCap holds a multidisciplinary advisory board meeting on Barrett’s esophagus

EsoCap supports first European EoE Day of the European Society of Eosinophilic Oesophagitis on May 22, 2022

EsoCap AG

Legal

Sitemap